Wide-reaching report finds strong support for nurse and pharmacist prescribing

Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report

 

Southampton (May 10, 2011) – Greater powers introduced by the government to enable specially trained nurses and pharmacists to prescribe medication in England have been successfully adopted, according to a new report.

 

Health service researchers from the universities of Southampton and Keele found widespread acceptance of the new powers among patients and that prescribing practices were safe and appropriate for the type of medical conditions being treated.

 

The Department of Health-funded report, published today (Tuesday, 10 May 2011), gives a national ‘snapshot’ of how successfully nurse and pharmacist prescribing is being used in primary care trusts, GP surgeries and hospitals.

 

"This study is the first national evaluation of independent prescribing by nurses and pharmacists since legislation in 2006 enabled nurses and pharmacists to independently prescribe across an extensive range of medicines. Our research shows that the practice is becoming a well–integrated and established means of managing a patient’s condition," comments Sue Latter, professor of nursing at the University of Southampton, who led the study.

 

"We were also able to highlight areas to the government where expansion of non-medical prescribing could strengthen NHS services in order to meet health care needs of the future."

 

The legislation, which gave experienced nurses and pharmacists powers to prescribe medication to patients, was viewed by some as controversial when it was introduced in 2006. Specially trained nurses and pharmacists in England are now able to manage all aspects of a patient’s treatment including diagnosis, prescription and monitoring, without supervision by a doctor.

 

"Our research shows that nurse and pharmacist independent prescribers are now making a substantial contribution to patient care which is safe and of good quality," says Alison Blenkinsopp, professor of the practice of pharmacy at Keele University.

 

"Commissioners of healthcare can use our findings to make the most effective use of nurse and pharmacist prescribing when they are commissioning services."

 

The report also found that:

 

  • 86 per cent of nurses and 71 per cent of pharmacists are using their new powers after training as a prescriber.
  • Most nurses and pharmacists are prescribing in a primary care setting, with substantial numbers also in secondary care settings, such as hospitals.
  • Most patients did not mind whether they received care from a nurse, pharmacist or a doctor.
  • Enabling non-medical prescribing to develop further, by additional training of nurses and pharmacists to treat patients with more than one medical condition, could improve patient care and efficiency in the health service.

 


 

University of Southampton, Sophie Docker; Nursing News 10.05.2011 (tB).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle
Deutscher Schmerz- und Palliativtag 2020 – ONLINE
Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…
DBfK: Besondere Rolle für Pflegeexpert/innen Schmerz – nicht nur in…

DIABETES

“Körperstolz”: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Finanzierung der ambulanten Krebsberatung weiterhin nicht gesichert
Lungenkrebsscreening mittels Low-Dose-CT

MULTIPLE SKLEROSE

Geschützt: Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…